Search for Clinical Trial Results
Prurigo Nodularis - 1 Studies Found
| Status | Study |
| Completed |
Study Name: A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Participants With Prurigo Nodularis (PN) Condition: Prurigo Nodularis Date: 2025-05-15 Interventions: Ruxolitinib cream 1.5% twice daily (BID) during the continuous and open label treatment period. |